Philip Needleman

Title: The Innovations of Philip Needleman

Introduction

Philip Needleman is a notable inventor based in Creve Coeur, Missouri. He has made significant contributions to the field of radiopharmaceuticals, particularly in the localization of thrombus within the mammalian body. His work has implications for both diagnostic imaging and therapeutic applications.

Latest Patents

Philip Needleman holds a patent for a radiopharmaceutical composition capable of localizing at sites of thrombus containing activated platelets. This innovative radiopharmaceutical comprises a linear peptidomimetic containing a ligand that specifically binds to the GPIIb/IIIa integrin receptor of platelets in the thrombus. The composition is designed to be complexed with a selected metal radionuclide, enabling it to serve as either a diagnostic tool for imaging thrombus sites or a therapeutic agent for radiotherapy.

Career Highlights

Throughout his career, Needleman has been associated with G.D. Searle & Company, where he has furthered his research and development in the field of pharmaceuticals. His work has led to advancements in medical imaging and treatment options for patients suffering from thrombotic conditions.

Collaborations

Philip Needleman has collaborated with notable colleagues such as Ananthachari Srinivasan and Larry P. Feigen. These partnerships have contributed to the success and impact of his innovations in the medical field.

Conclusion

Philip Needleman's contributions to radiopharmaceuticals exemplify the intersection of innovation and healthcare. His patented work continues to influence diagnostic and therapeutic practices in medicine.